The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pain Treatment Medication Market Research Report 2025
Synopsis
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
The global Pain Treatment Medication market was valued at US$ 72000 million in 2023 and is anticipated to reach US$ 96030 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pain Treatment Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Treatment Medication.
Report Scope
The Pain Treatment Medication market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Treatment Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Treatment Medication companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc. (Allergan plc)
Bristol Myers Squibb Co.
Sanofi S.A.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
GSK plc.
Abbott Laboratories, Inc.
Novartis AG
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Procter & Gamble
AstraZeneca
Cardinal Health
Perrigo Company Plc.
Bausch Health Companies Inc.
Viatris
Amneal Pharmaceuticals
Purdue Pharmaceuticals L.P.
Segment by Type
Opioids
NSAIDs
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pain Treatment Medication companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
The global Pain Treatment Medication market was valued at US$ 72000 million in 2023 and is anticipated to reach US$ 96030 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pain Treatment Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Treatment Medication.
Report Scope
The Pain Treatment Medication market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Treatment Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Treatment Medication companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc. (Allergan plc)
Bristol Myers Squibb Co.
Sanofi S.A.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
GSK plc.
Abbott Laboratories, Inc.
Novartis AG
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Procter & Gamble
AstraZeneca
Cardinal Health
Perrigo Company Plc.
Bausch Health Companies Inc.
Viatris
Amneal Pharmaceuticals
Purdue Pharmaceuticals L.P.
Segment by Type
Opioids
NSAIDs
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pain Treatment Medication companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pain Treatment Medication Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Opioids
1.2.3 NSAIDs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pain Treatment Medication Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pain Treatment Medication Market Perspective (2019-2030)
2.2 Pain Treatment Medication Growth Trends by Region
2.2.1 Global Pain Treatment Medication Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pain Treatment Medication Historic Market Size by Region (2019-2024)
2.2.3 Pain Treatment Medication Forecasted Market Size by Region (2025-2030)
2.3 Pain Treatment Medication Market Dynamics
2.3.1 Pain Treatment Medication Industry Trends
2.3.2 Pain Treatment Medication Market Drivers
2.3.3 Pain Treatment Medication Market Challenges
2.3.4 Pain Treatment Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pain Treatment Medication Players by Revenue
3.1.1 Global Top Pain Treatment Medication Players by Revenue (2019-2024)
3.1.2 Global Pain Treatment Medication Revenue Market Share by Players (2019-2024)
3.2 Global Pain Treatment Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pain Treatment Medication Revenue
3.4 Global Pain Treatment Medication Market Concentration Ratio
3.4.1 Global Pain Treatment Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pain Treatment Medication Revenue in 2023
3.5 Pain Treatment Medication Key Players Head office and Area Served
3.6 Key Players Pain Treatment Medication Product Solution and Service
3.7 Date of Enter into Pain Treatment Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pain Treatment Medication Breakdown Data by Type
4.1 Global Pain Treatment Medication Historic Market Size by Type (2019-2024)
4.2 Global Pain Treatment Medication Forecasted Market Size by Type (2025-2030)
5 Pain Treatment Medication Breakdown Data by Application
5.1 Global Pain Treatment Medication Historic Market Size by Application (2019-2024)
5.2 Global Pain Treatment Medication Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pain Treatment Medication Market Size (2019-2030)
6.2 North America Pain Treatment Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pain Treatment Medication Market Size by Country (2019-2024)
6.4 North America Pain Treatment Medication Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pain Treatment Medication Market Size (2019-2030)
7.2 Europe Pain Treatment Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pain Treatment Medication Market Size by Country (2019-2024)
7.4 Europe Pain Treatment Medication Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pain Treatment Medication Market Size (2019-2030)
8.2 Asia-Pacific Pain Treatment Medication Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pain Treatment Medication Market Size by Region (2019-2024)
8.4 Asia-Pacific Pain Treatment Medication Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pain Treatment Medication Market Size (2019-2030)
9.2 Latin America Pain Treatment Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pain Treatment Medication Market Size by Country (2019-2024)
9.4 Latin America Pain Treatment Medication Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pain Treatment Medication Market Size (2019-2030)
10.2 Middle East & Africa Pain Treatment Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pain Treatment Medication Market Size by Country (2019-2024)
10.4 Middle East & Africa Pain Treatment Medication Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc. (Allergan plc)
11.1.1 AbbVie Inc. (Allergan plc) Company Detail
11.1.2 AbbVie Inc. (Allergan plc) Business Overview
11.1.3 AbbVie Inc. (Allergan plc) Pain Treatment Medication Introduction
11.1.4 AbbVie Inc. (Allergan plc) Revenue in Pain Treatment Medication Business (2019-2024)
11.1.5 AbbVie Inc. (Allergan plc) Recent Development
11.2 Bristol Myers Squibb Co.
11.2.1 Bristol Myers Squibb Co. Company Detail
11.2.2 Bristol Myers Squibb Co. Business Overview
11.2.3 Bristol Myers Squibb Co. Pain Treatment Medication Introduction
11.2.4 Bristol Myers Squibb Co. Revenue in Pain Treatment Medication Business (2019-2024)
11.2.5 Bristol Myers Squibb Co. Recent Development
11.3 Sanofi S.A.
11.3.1 Sanofi S.A. Company Detail
11.3.2 Sanofi S.A. Business Overview
11.3.3 Sanofi S.A. Pain Treatment Medication Introduction
11.3.4 Sanofi S.A. Revenue in Pain Treatment Medication Business (2019-2024)
11.3.5 Sanofi S.A. Recent Development
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Detail
11.4.2 Boehringer Ingelheim International GmbH Business Overview
11.4.3 Boehringer Ingelheim International GmbH Pain Treatment Medication Introduction
11.4.4 Boehringer Ingelheim International GmbH Revenue in Pain Treatment Medication Business (2019-2024)
11.4.5 Boehringer Ingelheim International GmbH Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Detail
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Pain Treatment Medication Introduction
11.5.4 Pfizer Inc. Revenue in Pain Treatment Medication Business (2019-2024)
11.5.5 Pfizer Inc. Recent Development
11.6 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
11.6.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Detail
11.6.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
11.6.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Pain Treatment Medication Introduction
11.6.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue in Pain Treatment Medication Business (2019-2024)
11.6.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Development
11.7 GSK plc.
11.7.1 GSK plc. Company Detail
11.7.2 GSK plc. Business Overview
11.7.3 GSK plc. Pain Treatment Medication Introduction
11.7.4 GSK plc. Revenue in Pain Treatment Medication Business (2019-2024)
11.7.5 GSK plc. Recent Development
11.8 Abbott Laboratories, Inc.
11.8.1 Abbott Laboratories, Inc. Company Detail
11.8.2 Abbott Laboratories, Inc. Business Overview
11.8.3 Abbott Laboratories, Inc. Pain Treatment Medication Introduction
11.8.4 Abbott Laboratories, Inc. Revenue in Pain Treatment Medication Business (2019-2024)
11.8.5 Abbott Laboratories, Inc. Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Detail
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Pain Treatment Medication Introduction
11.9.4 Novartis AG Revenue in Pain Treatment Medication Business (2019-2024)
11.9.5 Novartis AG Recent Development
11.10 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
11.10.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Detail
11.10.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
11.10.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Pain Treatment Medication Introduction
11.10.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Pain Treatment Medication Business (2019-2024)
11.10.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development
11.11 Sun Pharmaceutical Industries Ltd.
11.11.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.11.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd. Pain Treatment Medication Introduction
11.11.4 Sun Pharmaceutical Industries Ltd. Revenue in Pain Treatment Medication Business (2019-2024)
11.11.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.12 Teva Pharmaceuticals Ltd.
11.12.1 Teva Pharmaceuticals Ltd. Company Detail
11.12.2 Teva Pharmaceuticals Ltd. Business Overview
11.12.3 Teva Pharmaceuticals Ltd. Pain Treatment Medication Introduction
11.12.4 Teva Pharmaceuticals Ltd. Revenue in Pain Treatment Medication Business (2019-2024)
11.12.5 Teva Pharmaceuticals Ltd. Recent Development
11.13 Mallinckrodt Pharmaceuticals
11.13.1 Mallinckrodt Pharmaceuticals Company Detail
11.13.2 Mallinckrodt Pharmaceuticals Business Overview
11.13.3 Mallinckrodt Pharmaceuticals Pain Treatment Medication Introduction
11.13.4 Mallinckrodt Pharmaceuticals Revenue in Pain Treatment Medication Business (2019-2024)
11.13.5 Mallinckrodt Pharmaceuticals Recent Development
11.14 Endo Pharmaceuticals Inc.
11.14.1 Endo Pharmaceuticals Inc. Company Detail
11.14.2 Endo Pharmaceuticals Inc. Business Overview
11.14.3 Endo Pharmaceuticals Inc. Pain Treatment Medication Introduction
11.14.4 Endo Pharmaceuticals Inc. Revenue in Pain Treatment Medication Business (2019-2024)
11.14.5 Endo Pharmaceuticals Inc. Recent Development
11.15 Bayer AG
11.15.1 Bayer AG Company Detail
11.15.2 Bayer AG Business Overview
11.15.3 Bayer AG Pain Treatment Medication Introduction
11.15.4 Bayer AG Revenue in Pain Treatment Medication Business (2019-2024)
11.15.5 Bayer AG Recent Development
11.16 F. Hoffmann-La Roche Ltd.
11.16.1 F. Hoffmann-La Roche Ltd. Company Detail
11.16.2 F. Hoffmann-La Roche Ltd. Business Overview
11.16.3 F. Hoffmann-La Roche Ltd. Pain Treatment Medication Introduction
11.16.4 F. Hoffmann-La Roche Ltd. Revenue in Pain Treatment Medication Business (2019-2024)
11.16.5 F. Hoffmann-La Roche Ltd. Recent Development
11.17 Procter & Gamble
11.17.1 Procter & Gamble Company Detail
11.17.2 Procter & Gamble Business Overview
11.17.3 Procter & Gamble Pain Treatment Medication Introduction
11.17.4 Procter & Gamble Revenue in Pain Treatment Medication Business (2019-2024)
11.17.5 Procter & Gamble Recent Development
11.18 AstraZeneca
11.18.1 AstraZeneca Company Detail
11.18.2 AstraZeneca Business Overview
11.18.3 AstraZeneca Pain Treatment Medication Introduction
11.18.4 AstraZeneca Revenue in Pain Treatment Medication Business (2019-2024)
11.18.5 AstraZeneca Recent Development
11.19 Cardinal Health
11.19.1 Cardinal Health Company Detail
11.19.2 Cardinal Health Business Overview
11.19.3 Cardinal Health Pain Treatment Medication Introduction
11.19.4 Cardinal Health Revenue in Pain Treatment Medication Business (2019-2024)
11.19.5 Cardinal Health Recent Development
11.20 Perrigo Company Plc.
11.20.1 Perrigo Company Plc. Company Detail
11.20.2 Perrigo Company Plc. Business Overview
11.20.3 Perrigo Company Plc. Pain Treatment Medication Introduction
11.20.4 Perrigo Company Plc. Revenue in Pain Treatment Medication Business (2019-2024)
11.20.5 Perrigo Company Plc. Recent Development
11.21 Bausch Health Companies Inc.
11.21.1 Bausch Health Companies Inc. Company Detail
11.21.2 Bausch Health Companies Inc. Business Overview
11.21.3 Bausch Health Companies Inc. Pain Treatment Medication Introduction
11.21.4 Bausch Health Companies Inc. Revenue in Pain Treatment Medication Business (2019-2024)
11.21.5 Bausch Health Companies Inc. Recent Development
11.22 Viatris
11.22.1 Viatris Company Detail
11.22.2 Viatris Business Overview
11.22.3 Viatris Pain Treatment Medication Introduction
11.22.4 Viatris Revenue in Pain Treatment Medication Business (2019-2024)
11.22.5 Viatris Recent Development
11.23 Amneal Pharmaceuticals
11.23.1 Amneal Pharmaceuticals Company Detail
11.23.2 Amneal Pharmaceuticals Business Overview
11.23.3 Amneal Pharmaceuticals Pain Treatment Medication Introduction
11.23.4 Amneal Pharmaceuticals Revenue in Pain Treatment Medication Business (2019-2024)
11.23.5 Amneal Pharmaceuticals Recent Development
11.24 Purdue Pharmaceuticals L.P.
11.24.1 Purdue Pharmaceuticals L.P. Company Detail
11.24.2 Purdue Pharmaceuticals L.P. Business Overview
11.24.3 Purdue Pharmaceuticals L.P. Pain Treatment Medication Introduction
11.24.4 Purdue Pharmaceuticals L.P. Revenue in Pain Treatment Medication Business (2019-2024)
11.24.5 Purdue Pharmaceuticals L.P. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pain Treatment Medication Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Opioids
Table 3. Key Players of NSAIDs
Table 4. Key Players of Others
Table 5. Global Pain Treatment Medication Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pain Treatment Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pain Treatment Medication Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Pain Treatment Medication Market Share by Region (2019-2024)
Table 9. Global Pain Treatment Medication Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Pain Treatment Medication Market Share by Region (2025-2030)
Table 11. Pain Treatment Medication Market Trends
Table 12. Pain Treatment Medication Market Drivers
Table 13. Pain Treatment Medication Market Challenges
Table 14. Pain Treatment Medication Market Restraints
Table 15. Global Pain Treatment Medication Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Pain Treatment Medication Market Share by Players (2019-2024)
Table 17. Global Top Pain Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Treatment Medication as of 2023)
Table 18. Ranking of Global Top Pain Treatment Medication Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Pain Treatment Medication Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pain Treatment Medication Product Solution and Service
Table 22. Date of Enter into Pain Treatment Medication Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pain Treatment Medication Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Pain Treatment Medication Revenue Market Share by Type (2019-2024)
Table 26. Global Pain Treatment Medication Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Pain Treatment Medication Revenue Market Share by Type (2025-2030)
Table 28. Global Pain Treatment Medication Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Pain Treatment Medication Revenue Market Share by Application (2019-2024)
Table 30. Global Pain Treatment Medication Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Pain Treatment Medication Revenue Market Share by Application (2025-2030)
Table 32. North America Pain Treatment Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Pain Treatment Medication Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Pain Treatment Medication Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Pain Treatment Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Pain Treatment Medication Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Pain Treatment Medication Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Pain Treatment Medication Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Pain Treatment Medication Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Pain Treatment Medication Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Pain Treatment Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Pain Treatment Medication Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Pain Treatment Medication Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Pain Treatment Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Pain Treatment Medication Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Pain Treatment Medication Market Size by Country (2025-2030) & (US$ Million)
Table 47. AbbVie Inc. (Allergan plc) Company Detail
Table 48. AbbVie Inc. (Allergan plc) Business Overview
Table 49. AbbVie Inc. (Allergan plc) Pain Treatment Medication Product
Table 50. AbbVie Inc. (Allergan plc) Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 51. AbbVie Inc. (Allergan plc) Recent Development
Table 52. Bristol Myers Squibb Co. Company Detail
Table 53. Bristol Myers Squibb Co. Business Overview
Table 54. Bristol Myers Squibb Co. Pain Treatment Medication Product
Table 55. Bristol Myers Squibb Co. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 56. Bristol Myers Squibb Co. Recent Development
Table 57. Sanofi S.A. Company Detail
Table 58. Sanofi S.A. Business Overview
Table 59. Sanofi S.A. Pain Treatment Medication Product
Table 60. Sanofi S.A. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 61. Sanofi S.A. Recent Development
Table 62. Boehringer Ingelheim International GmbH Company Detail
Table 63. Boehringer Ingelheim International GmbH Business Overview
Table 64. Boehringer Ingelheim International GmbH Pain Treatment Medication Product
Table 65. Boehringer Ingelheim International GmbH Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 66. Boehringer Ingelheim International GmbH Recent Development
Table 67. Pfizer Inc. Company Detail
Table 68. Pfizer Inc. Business Overview
Table 69. Pfizer Inc. Pain Treatment Medication Product
Table 70. Pfizer Inc. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 71. Pfizer Inc. Recent Development
Table 72. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Detail
Table 73. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
Table 74. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Pain Treatment Medication Product
Table 75. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 76. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Development
Table 77. GSK plc. Company Detail
Table 78. GSK plc. Business Overview
Table 79. GSK plc. Pain Treatment Medication Product
Table 80. GSK plc. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 81. GSK plc. Recent Development
Table 82. Abbott Laboratories, Inc. Company Detail
Table 83. Abbott Laboratories, Inc. Business Overview
Table 84. Abbott Laboratories, Inc. Pain Treatment Medication Product
Table 85. Abbott Laboratories, Inc. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 86. Abbott Laboratories, Inc. Recent Development
Table 87. Novartis AG Company Detail
Table 88. Novartis AG Business Overview
Table 89. Novartis AG Pain Treatment Medication Product
Table 90. Novartis AG Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 91. Novartis AG Recent Development
Table 92. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Detail
Table 93. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
Table 94. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Pain Treatment Medication Product
Table 95. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 96. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development
Table 97. Sun Pharmaceutical Industries Ltd. Company Detail
Table 98. Sun Pharmaceutical Industries Ltd. Business Overview
Table 99. Sun Pharmaceutical Industries Ltd. Pain Treatment Medication Product
Table 100. Sun Pharmaceutical Industries Ltd. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 101. Sun Pharmaceutical Industries Ltd. Recent Development
Table 102. Teva Pharmaceuticals Ltd. Company Detail
Table 103. Teva Pharmaceuticals Ltd. Business Overview
Table 104. Teva Pharmaceuticals Ltd. Pain Treatment Medication Product
Table 105. Teva Pharmaceuticals Ltd. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 106. Teva Pharmaceuticals Ltd. Recent Development
Table 107. Mallinckrodt Pharmaceuticals Company Detail
Table 108. Mallinckrodt Pharmaceuticals Business Overview
Table 109. Mallinckrodt Pharmaceuticals Pain Treatment Medication Product
Table 110. Mallinckrodt Pharmaceuticals Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 111. Mallinckrodt Pharmaceuticals Recent Development
Table 112. Endo Pharmaceuticals Inc. Company Detail
Table 113. Endo Pharmaceuticals Inc. Business Overview
Table 114. Endo Pharmaceuticals Inc. Pain Treatment Medication Product
Table 115. Endo Pharmaceuticals Inc. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 116. Endo Pharmaceuticals Inc. Recent Development
Table 117. Bayer AG Company Detail
Table 118. Bayer AG Business Overview
Table 119. Bayer AG Pain Treatment Medication Product
Table 120. Bayer AG Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 121. Bayer AG Recent Development
Table 122. F. Hoffmann-La Roche Ltd. Company Detail
Table 123. F. Hoffmann-La Roche Ltd. Business Overview
Table 124. F. Hoffmann-La Roche Ltd. Pain Treatment Medication Product
Table 125. F. Hoffmann-La Roche Ltd. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 126. F. Hoffmann-La Roche Ltd. Recent Development
Table 127. Procter & Gamble Company Detail
Table 128. Procter & Gamble Business Overview
Table 129. Procter & Gamble Pain Treatment Medication Product
Table 130. Procter & Gamble Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 131. Procter & Gamble Recent Development
Table 132. AstraZeneca Company Detail
Table 133. AstraZeneca Business Overview
Table 134. AstraZeneca Pain Treatment Medication Product
Table 135. AstraZeneca Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 136. AstraZeneca Recent Development
Table 137. Cardinal Health Company Detail
Table 138. Cardinal Health Business Overview
Table 139. Cardinal Health Pain Treatment Medication Product
Table 140. Cardinal Health Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 141. Cardinal Health Recent Development
Table 142. Perrigo Company Plc. Company Detail
Table 143. Perrigo Company Plc. Business Overview
Table 144. Perrigo Company Plc. Pain Treatment Medication Product
Table 145. Perrigo Company Plc. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 146. Perrigo Company Plc. Recent Development
Table 147. Bausch Health Companies Inc. Company Detail
Table 148. Bausch Health Companies Inc. Business Overview
Table 149. Bausch Health Companies Inc. Pain Treatment Medication Product
Table 150. Bausch Health Companies Inc. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 151. Bausch Health Companies Inc. Recent Development
Table 152. Viatris Company Detail
Table 153. Viatris Business Overview
Table 154. Viatris Pain Treatment Medication Product
Table 155. Viatris Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 156. Viatris Recent Development
Table 157. Amneal Pharmaceuticals Company Detail
Table 158. Amneal Pharmaceuticals Business Overview
Table 159. Amneal Pharmaceuticals Pain Treatment Medication Product
Table 160. Amneal Pharmaceuticals Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 161. Amneal Pharmaceuticals Recent Development
Table 162. Purdue Pharmaceuticals L.P. Company Detail
Table 163. Purdue Pharmaceuticals L.P. Business Overview
Table 164. Purdue Pharmaceuticals L.P. Pain Treatment Medication Product
Table 165. Purdue Pharmaceuticals L.P. Revenue in Pain Treatment Medication Business (2019-2024) & (US$ Million)
Table 166. Purdue Pharmaceuticals L.P. Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pain Treatment Medication Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pain Treatment Medication Market Share by Type: 2023 VS 2030
Figure 3. Opioids Features
Figure 4. NSAIDs Features
Figure 5. Others Features
Figure 6. Global Pain Treatment Medication Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pain Treatment Medication Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Drugstores Case Studies
Figure 10. Others Case Studies
Figure 11. Pain Treatment Medication Report Years Considered
Figure 12. Global Pain Treatment Medication Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Pain Treatment Medication Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pain Treatment Medication Market Share by Region: 2023 VS 2030
Figure 15. Global Pain Treatment Medication Market Share by Players in 2023
Figure 16. Global Top Pain Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Treatment Medication as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Pain Treatment Medication Revenue in 2023
Figure 18. North America Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Pain Treatment Medication Market Share by Country (2019-2030)
Figure 20. United States Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pain Treatment Medication Market Share by Country (2019-2030)
Figure 24. Germany Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pain Treatment Medication Market Share by Region (2019-2030)
Figure 32. China Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pain Treatment Medication Market Share by Country (2019-2030)
Figure 40. Mexico Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pain Treatment Medication Market Share by Country (2019-2030)
Figure 44. Turkey Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Pain Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. AbbVie Inc. (Allergan plc) Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 47. Bristol Myers Squibb Co. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 48. Sanofi S.A. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 49. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 50. Pfizer Inc. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 51. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 52. GSK plc. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 53. Abbott Laboratories, Inc. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 54. Novartis AG Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 55. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 56. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 57. Teva Pharmaceuticals Ltd. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 58. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 59. Endo Pharmaceuticals Inc. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 60. Bayer AG Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 61. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 62. Procter & Gamble Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 63. AstraZeneca Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 64. Cardinal Health Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 65. Perrigo Company Plc. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 66. Bausch Health Companies Inc. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 67. Viatris Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 68. Amneal Pharmaceuticals Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 69. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Pain Treatment Medication Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
